Zhitong Financial App News, Zhendong Pharmaceutical (300158.SZ) issued an announcement. In order to meet strategic development needs, make full use of the strength and resource advantages of professional investment institutions, integrate multiple resources to obtain long-term investment returns and enhance comprehensive competitiveness, without affecting the company's daily operations and development, and effectively control investment risks, the company recently signed the “Wenzhou Longmen Private Equity Fund Management Partnership (Limited Partnership), Wen Nuoyao, Beijing Xinyi Consulting Co., Ltd., Shanghai Vinuo Runcheng Pharmaceutical Technology Co., Ltd. (Partnership) Partnership Agreement”. According to the partnership agreement, the company, as a limited partner, has pledged an investment of RMB 30 million with its own capital, with an investment ratio of 28.5687%. It bears limited liability up to the amount of pledged capital, and mainly invests in the biomedical sector.

Zhitong Financial App News, Zhendong Pharmaceutical (300158.SZ) issued an announcement. In order to meet strategic development needs, make full use of the strength and resource advantages of professional investment institutions, integrate multiple resources to obtain long-term investment returns and enhance comprehensive competitiveness, without affecting the company's daily operations and development, and effectively control investment risks, the company recently signed the “Wenzhou Longmen Private Equity Fund Management Partnership (Limited Partnership), Wen Nuoyao, Beijing Xinyi Consulting Co., Ltd., Shanghai Vinuo Runcheng Pharmaceutical Technology Co., Ltd. (Partnership) Partnership Agreement”. According to the partnership agreement, the company, as a limited partner, has pledged an investment of RMB 30 million with its own capital, with an investment ratio of 28.5687%. It bears limited liability up to the amount of pledged capital, and mainly invests in the biomedical sector.